Connecticut House Bill HB06152

Connecticut 2019 Regular Session

• Introduced: 1/24/19
• Refer: 1/24/19

Caption

An Act Requiring The Inclusion Of Methadone In The Electronic Prescription Drug Monitoring Program.

Impact

If enacted, HB 6152 would have significant implications for state laws surrounding prescription medications and the management of controlled substances. The inclusion of methadone in the PDMP would require all practitioners who prescribe methadone to report their prescriptions into the state database, which would allow regulatory bodies to have a comprehensive view of prescribing practices. This measure is also expected to enhance patient safety by preventing prescription duplication and misuse and could potentially aid in combating the opioid crisis more effectively.

Summary

House Bill 6152 seeks to enhance the oversight of methadone prescriptions by mandating their inclusion in the Electronic Prescription Drug Monitoring Program (PDMP) of the state. The bill aims to assist in tracking the dispensation of methadone, primarily used in treating opioid addiction, thereby improving the state's ability to monitor prescription practices and curb potential abuse. By requiring the Commissioner of Consumer Protection to incorporate methadone into the existing monitoring framework, the bill intends to increase accountability among healthcare providers and pharmacies dispensing this medication.

Contention

While the bill has strong support focused on its public health benefits, there may be notable points of contention among stakeholders regarding the execution of this requirement. Concerns may arise from healthcare providers who fear that increased regulation could hinder their ability to treat patients effectively, particularly those requiring stable doses of methadone as part of their recovery plans. Additionally, patient advocacy groups might express worries that stringent monitoring could lead to stigmatization of those seeking treatment for addiction, thus seeking a balance between accountability and accessible care.